Chargement en cours...
Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
BACKGROUND & AIMS: Availability of directly-acting antivirals (DAAs) has changed the treatment landscape of hepatitis C virus (HCV) infection. The high price of DAAs has restricted their use in several countries. However, in some countries such as India, generic DAAs are available at much cheape...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5435174/ https://ncbi.nlm.nih.gov/pubmed/28520728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0176503 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|